title: Antagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?
authors.affiliation: University of Connecticut Health Center, Farmington, Connecticut 06030-1111, USA. Freston@NSO.UCHC.edu
authors.forename: J W
authors.initials: JW
authors.lastname: Freston
mesh_terms: D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008875:Middle Aged
chemical_list: D000897:Anti-Ulcer Agents